Dec 29, 2025
Fusion Fuel Strikes Deal To Unlock $33 Million For Green Hydrogen Projects

Fusion Fuel Green PLC (NASDAQ:HTOO) said Monday that its wholly-owned subsidiary has entered into agreements with a green energy technologies provider to establish Bright Hydrogen Holding Company Limited. Details This new entity will serve as a dedicated platform for developing,…

Dec 29, 2025
Check Out What Whales Are Doing With ORCL

Whales with a lot of money to spend have taken a noticeably bullish stance on Oracle. Looking at options history for Oracle (NYSE:ORCL) we detected 45 trades. If we consider the specifics of each trade, it is accurate to state…

Dec 29, 2025
Merck & Co Unusual Options Activity

High-rolling investors have positioned themselves bullish on Merck & Co (NYSE:MRK), and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors…

Dec 29, 2025
Price Over Earnings Overview: BlackRock

In the current market session, BlackRock Inc. (NYSE:BLK) stock price is at $1085.47, after a 0.24% decrease. However, over the past month, the company's stock spiked by 4.51%, and in the past year, by 5.89%. Shareholders might be interested in…

Dec 29, 2025
Tutor Perini Wins $53 Million Rail Expansion Order In Honolulu

Tutor Perini Corporation (NYSE:TPC) said Monday it has been awarded a design change order valued at approximately $53 million for the City Center Guideway and Stations Project in Honolulu, Hawaii. The award expands the company's role on the project by…

Dec 29, 2025
SoftBank Buys DigitalBridge In $4 Billion AI Infrastructure Play

SoftBank Group Corp.  (OTC:SFTBF) (OTC:SFTBY) said Monday it has agreed to acquire DigitalBridge Group Inc. (NYSE:DBRG) in a cash deal valued at about $4 billion, marking a significant step in its push to scale global infrastructure for artificial intelligence. Under the…

Dec 29, 2025
Ultragenyx-Mereo Bone Drug Trial Disappoints, Stocks Hit 52-Week Lows

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO) stocks hit their 52-week low on Monday, as per data from Benzinga Pro. Mereo BioPharma and its partner Ultragenyx revealed results from the Phase 3 Orbit and Cosmic studies for…